Publications:

Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19.

Acta Pharmaceutica Sinica. B

Yi, Yang Y; Zhang, Meng M; Xue, Heng H; Yu, Rong R; Bao, Yang-Oujie YO; Kuang, Yi Y; Chai, Yue Y; Ma, Wen W; Wang, Jing J; Shi, Xiaomeng X; Li, Wenzhe W; Hong, Wei W; Li, Junhua J; Muturi, Elishiba E; Wei, Hongping H; Wlodarz, Joachim J; Roszak, Szczepan S; Qiao, Xue X; Yang, Hang H; Ye, Min M

Publication Date: 2022-11

Variant appearance in text: GPNMB: H41A

PubMed Link: 35968270

Variant Present in the following documents:

• mmc1.pdf

View BVdb publication page